Genpact (NYSE:G) has declared a cash dividend of $0.17 per share for the fourth quarter of 2025. This provides investors with some income, even as the company contends with muted growth and operational pressures.

See our latest analysis for Genpact.

After a tough stretch marked by waning demand and rising investment needs, Genpact’s share price has trended lower this year, slipping over 7% since January. Despite those headwinds, the stock’s one-year total shareholder return is up 2.9%, suggesting that dividends and modest gains have cushioned some of the price weakness. Longer-term returns remain well below their peak as soft growth expectations keep momentum muted for now.

If you’re looking to broaden your search beyond Genpact, now is an ideal time to discover fast growing stocks with high insider ownership

With the stock trading at a steep discount to analyst price targets and growth expectations muted, investors are left to decide whether Genpact’s current valuation signals an overlooked opportunity or if markets have already factored its outlook into the price.

Genpact closed at $39.86, while the narrative fair value calculation lands at $52.44 per share. This sizable gap highlights optimism among those tracking growth, digital transformation, and AI adoption at the company.

*\\"Accelerated client adoption of Genpact's Advanced Technology Solutions, particularly in data and AI, should drive higher growth and improved margins, as these offerings deliver over twice the revenue per headcount versus legacy services and are expanding at over twice the company's overall rate, pointing toward robust long-term revenue and margin expansion.\\"*

Read the complete narrative.

Ever wonder which hidden levers drive a richer fair value? The narrative rests on a future where rapid changes power both growth and margin upgrades. Only those who look closer will see the underlying assumptions that make this valuation so compelling.

Result: Fair Value of $52.44 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, slowing legacy business growth or weaker-than-expected demand could undermine Genpact’s outlook and create challenges for achieving higher margins.

Find out about the key risks to this Genpact narrative.

If you see the story differently or want to dig into the numbers yourself, you can build your own narrative in just a few minutes. Do it your way

A great starting point for your Genpact research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Expand your portfolio with confidence using Simply Wall Street’s powerful Screener. These investment themes could reveal the next winner you want to catch before everyone else jumps in.

Unearth income potential, targeting attractive yields with 3%;elm:context_link;itc:0;sec:content-canvas\\" class=\\"link \\">these 18 dividend stocks with yields > 3% that consistently deliver strong returns above 3%.

Target the innovation frontiers, seizing early momentum from these 26 quantum computing stocks as they push boundaries in game-changing technology.

Catch tomorrow’s leaders by evaluating these 25 AI penny stocks at the forefront of artificial intelligence breakthroughs and high-growth promise.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include G.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com